Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Medesis Pharma SA

76D
Current price
0.49 EUR 0 EUR (0.00%)
Last closed 0.55 EUR
ISIN FR0010844464
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 2 569 584 EUR
Yield for 12 month -57.38 %
1Y
3Y
5Y
10Y
15Y
76D
21.11.2021 - 28.11.2021

Medesis Pharma S.A. operates as a biopharmaceutical company. The company's products include NanoLithium (NP03) for the treatment of Alzheimer's disease; NanosiRNA HD and NanoP42T to treat Huntington's disease; NanoLithium for the prevention and treatment of psychiatric disorders; NanoManganese (NP02), a radiation protection drug; and NU01 plutonium decorporation and NU02 cesium decorporation nuclear drugs. It also develops oncology drugs, including NanosiRNA IFNAR and NanoManganese Radiotherapy Glioblastoma. The company was founded in 2003 and is based in Montpellier, France. Address: L?Orée des Mas, Montpellier, France, 34670

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.97 EUR

P/E ratio

Dividend Yield

Current Year

+298 887 EUR

Last Year

+47 116 EUR

Current Quarter

+133 262 EUR

Last Quarter

+133 262 EUR

Current Year

-2 654 577 EUR

Last Year

-2 196 666 EUR

Current Quarter

-469 041 EUR

Last Quarter

-469 041 EUR

Key Figures 76D

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 918 311 EUR
Operating Margin TTM -7852.13 %
PE Ratio
Return On Assets TTM -137.6 %
PEG Ratio
Return On Equity TTM -934.59 %
Wall Street Target Price 2.97 EUR
Revenue TTM 298 886 EUR
Book Value -0.9 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -79.9 %
Dividend Yield
Gross Profit TTM -2 047 240 EUR
Earnings per share -0.8 EUR
Diluted Eps TTM -0.8 EUR
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 76D

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 76D

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 76D

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 12.9204
Price Sales TTM 8.5972
Enterprise Value EBITDA -3.5631
Price Book MRQ 108.2311

Financials 76D

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 76D

For 52 weeks

0.5 EUR 2.39 EUR
50 Day MA 0.82 EUR
Shares Short Prior Month
200 Day MA 1 EUR
Short Ratio
Shares Short
Short Percent